Drugs / Econazole
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT02720783 | Mar → Oct 2016 | — | Angelini Pharma | Completed | No outcome recorded |
| Phase 1 | NCT02713893 | Sep 2015 → Jun 2016 | — | Angelini Pharma | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT01696799 | Sep 2011 → Apr 2012 | tinea pedis | AmDerma | Completed | No outcome recorded |
| Phase 2 | NCT00385502 | Sep 2006 → Jun 2008 | tinea unguium | Abeona Therapeutics, Inc | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03129321 | Mar → Nov 2016 | tinea pedis | Mylan Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Econazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01696799 ↗ |
| Known as | Econazole Nitrate | “Econazole nitrate 150 mg plus Benzydamine HCl 6 mg vaginal pessary” NCT02720783 ↗1“Econazole Nitrate Cream, 1%” NCT03129321 ↗ |
| Route | Topical | “apply study drug daily to at least one affected great toenail” NCT00385502 ↗ |